Using Hyperthermia to Augment Drug Delivery - Physics of Thermal Therapy - page 289

Malmstrom, P. U., Sylvester, R. J., Crawford, D. E. , Friedrich, M.,
Krege, S., Rintala, E. et al. 2009 An individual patient data
meta-analysis of the long-term outcome of randomised
studies comparing intravesical mitomycin C versus Bacillus
Calmette-Guerin for non-muscle-invasive bladder cancer.
Eur Urol, 56(2): 247 -56.
Matteucci, M. L., Anyarambhatla, G., Rosner, G., Azuma, C.,
Fisher, P. E., Dewhirst, M. W. et al. 2000 Hyperthermia
increases accumulation of technetium-99m-labeled lipo-
somes in feline sarcomas. Clin Cancer Res , 6: 3748-55.
Minchinton, A. I., Tannock, I. F. 2006 Drug penetration in solid
tumours. Nat Rev Cancer , 6: 583-92.
Monsky, W. L., Kruskal, J. B., Lukyanov, A. N. et al. 2002 Radio-
frequency ablation increases intratumoral liposomal
doxorubicin accumulation in a rat breast tumor model.
Radiology , 224: 823-9.
Moon, E. J., Sonveaux, P., Porporato, P. E., Danhier, P., Gallez, B.,
Batinic-Haberle, I. et al. 2010 NADPH oxidase-mediated
reactive oxygen species production activates hypoxia-
inducible factor-1 (HIF-1) via the ERK pathway after
hyperthermia treatment. Proc Natl Acad Sci USA , 107:
20477-82.
Mostafa, E. M., Ganguli, S., Faintuch, S., Mertyna, P., Goldberg,
S. N. 2008 Optimal strategies for combining transcatheter
arterial chemoembolization and radiofrequency ablation in
rabbit VX2 hepatic tumors. J Vasc Interv Radiol , 19: 1740-8.
Mylonopoulou, E., Arvanitis, C. D., Bazan-Peregrino, M., Arora, M.,
Coussios, C. C. 2010. Ultrasonic activation of thermally sensi-
tive liposomes. In: 9th International Symposium on Therapeutic
Ultrasound. Edited by K. Hynynen and J. Souquet. Melville:
Amer Inst Physics, vol. 1215, pp. 83-87.
Needham, D., Anyarambhatla, G., Kong, G., Dewhirst, M. W.
2000 A new temperature-sensitive liposome for use with
mild hyperthermia: Characterization and testing in a
human tumor xenograft model. Cancer Res , 60: 1197-201.
Needham, D., Dewhirst, M. W. 2001 The development and testing
of a new temperature-sensitive drug delivery system for the
treatment of solid tumors. Adv Drug Deliv Rev , 53: 285-305.
Needham, D., Ponce, A. M. 2007 Nanoscale drug delivery vehicles
for solid tumors: A new paradigm for localized drug delivery
using temperature sensitive liposomes. In: Nanotechnology
for Cancer Therapy. . Edited by M. A. Mansoor. Boca Raton:
CRC Press, pp. 678-719.
Negussie, A. H., Yarmolenko, P. S., Partanen, A., Ranjan, A.,
Jacobs, G., Woods, D. et al. 2011 Formulation and charac-
terisation of magnetic resonance imageable thermally sen-
sitive liposomes for use with magnetic resonance-guided
high intensity focused ultrasound. Int J Hyperthermia , 27:
140-55.
O'Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E.,
Santoro, A. et al. 2004 Reduced cardiotoxicity and com-
parable efficacy in a phase III trial of pegylated liposomal
doxorubicin HCl (CAELYX (TM)/Doxil (R)) versus con-
ventional doxorubicin for first-line treatment of metastatic
breast cancer. Annals of Oncology , 15: 440-49.

Palmer, G., Boruta, R., Viglianti, B., Lan, L., Spasojevic, I.,
Dewhirst, M. 2010 Non-invasive monitoring of intra-tumor
drug concentration and therapeutic response using optical
spectroscopy. J Control Release , 142: 457-64.
Palmer, G. M., Boruta, R. J., Viglianti, B. L., Lan, L., Spasojevic,
I., Dewhirst, M. W. 2010 Non-invasive monitoring of intra-
tumor drug concentration and therapeutic response using
optical spectroscopy. Journal of Controlled Release , 142:
457-64.
Ponce, A. M., Viglianti, B. L., Yu, D. H., Yarmolenko, P. S.,
Michelich, C. R., Woo, J. et al. 2007 Magnetic resonance
imaging of temperature-sensitive liposome release: Drug
dose painting and antitumor effects. Journal of the National
Cancer Institute , 99: 53-63.
Poon, R. T., Borys, N. 2009 Lyso-thermosensitive liposomal
doxorubicin: A novel approach to enhance efficacy of ther-
mal ablation of liver cancer. Expert Opin Pharmacother , 10:
333-43.
Primeau, A. J., Rendon, A., Hedley, D., Lilge, L., Tannock, I. F.
2005 The distribution of the anticancer drug doxorubicin
in relation to blood vessels in solid tumors. Clin Cancer Res ,
11: 8782-8.
Ramanathan-Girish, S., Boroujerdi, M. 2001 Contradistinction
between doxorubicin and epirubicin: In-vitro interac-
tion with blood components. Journal of Pharmacy and
Pharmacology , 53: 815-21.
Riley, G. F., Lubitz, J. D.: Longitudinal patterns in medicare costs
for cancer decedents. In: Cancer Care and Cost: DRGs and
Beyond. Edited by R. M. Scheffler and N. C. Andrews. Ann
Arbor: Health Administration Press Perspectives, vol. 1, pp.
89-106, 1989
Riley, G. F., Potosky, A. L., Lubitz, J. D., Kessler, L. G. 1995
Medicare payments from diagnosis to death for elderly
cancer patients by stage at diagnosis. Med Care , 33:
828-41.
Sawhney, R., Bourgeois, D., Chaudhary, U. B. 2006 Neo-adjuvant
chemotherapy for muscle-invasive bladder cancer: A look
ahead. Ann Oncol , 17: 1360-9.
Shariat, S. F., Karakiewicz, P. I., Palapattu, G. S., Lotan, Y., Rogers,
C. G., Amiel, G. E. et al. 2006 Outcomes of radical cys-
tectomy for transitional cell carcinoma of the bladder: A
contemporary series from the Bladder Cancer Research
Consortium. J Urol , 176: 2414-22; discussion 22.
Shelley, M. D., Court, J. B., Kynaston, H., Wilt, T. J., Coles, B.,
Mason, M. 2003 Intravesical bacillus Calmette-Guerin ver-
sus mitomycin C for Ta and T1 bladder cancer. Cochrane
Database Syst Rev CD003231.
Shelley, M. D., Court, J. B., Kynaston, H., Wilt, T. J., Fish, R. G.,
Mason, M. 2000 Intravesical Bacillus Calmette-Guerin in
Ta and T1 Bladder Cancer. Cochrane Database Syst Rev
CD001986.
Song, C. W. 1984 Effect of local hyperthermia on blood flow and
microenvironment: A review. Cancer Res , 44: 4721s-30s.
Song, C. W., Park, H., Griffin, R. J. 2001 Improvement of tumor
oxygenation by mild hyperthermia. Radiat Res , 155: 515-28.